<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.SourceSummaryOutput xmlns:ns2="local"><SourceId>2026370</SourceId><Description>Other Publication</Description><Title>Phase II study of the safety, pharmacokinetics (PK) and efficacy of ceftazidime-avibactam plus metronidazole (CAZ-AVI+MTZ) compared with meropenem, in hospitalised paediatric patients with complicated intra-abdominal infection (cIAI)</Title><Authors><Author>John Bradley</Author><Author>Helen Broadhurst</Author><Author>Karen Cheng</Author><Author>Maria Mendez</Author><Author>Paul Newell</Author><Author>Gregory Stone</Author><Author>Angela Talley</Author><Author>Margaret Tawadrous</Author><Author>Dalia Wajsbrot</Author><Author>Katrina Yates</Author><Author>Antonina Zuzova</Author><Author>Annie Gardner</Author></Authors><Origin>European Congress of Clinical Microbiology and Infectious Diseases</Origin><PublicationDetails><Issue>April 22</Issue><Volume>28th</Volume><Year>2018</Year></PublicationDetails><isConferencePresentation>Yes</isConferencePresentation></ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.SourceSummaryOutput>